Richard Chau
WRITTEN BY Richard Chau
Breakthrough RNA Segment Editing Technology Offers New Hope for Treating Neurodegenerative Diseases
2026-06-05
Navigating the Translational Future of Cancer Care with ASCO 2026 Late-Breaking Abstracts
2026-06-02
Precision Combinations and Novel Modalities Redefine Head and Neck Cancer Care at ASCO 2026
2026-05-29
Protuoso Biosciences Launches with $9.5M to Pioneer AI-Driven “Hub-and-Spoke” Biologics Development
2026-05-27
Driving Global Healthcare Innovation: ASGH and Medical Fair 2026 Propel Industry Breakthroughs
2026-05-18
HanchorBio Presents Next Generation Tri-specific Biologics and Manufacturing Strategies at Biologics World Taiwan 2026
2026-05-14
From Detection to Cure: How Innovations and Collaborations Are Rewriting the Rare Disease Playbook
2026-05-13
CSO Insights at ASGH 2026: Navigating AI, Investments, and the Future of Patient-Centric Biotech
2026-05-13
Premier Medical Innovations and Strategic Investment Prospects Unveiled at ASGH and Hong Kong International Medical Fair
2026-05-07
The Next Decade in Cancer Therapeutics: How Immunotherapy is Evolving from Efficacy to Precision
2026-05-05
Global Cancer Research Output Reveals Bipolar Institutional Dominance and Emerging Market Opportunities
2026-04-30



